Page last updated: 2024-08-22

dideoxyadenosine and 3'-azido-2',3'-dideoxyguanosine

dideoxyadenosine has been researched along with 3'-azido-2',3'-dideoxyguanosine in 2 studies

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (50.00)	29.6817
2010's	1 (50.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Harada, Y; Liu, X; Mizushina, Y; Ogawara, T; Ogimura, Y; Saneyoshi, M; Takahashi, H; Yamaguchi, T	1
Asif, G; Coats, SJ; Detorio, M; Koontz, D; Mellors, JW; Meteer, JD; Schinazi, RF; Sluis-Cremer, N; Solomon, S; Zhang, HW	1

Other Studies

2 other study(ies) available for dideoxyadenosine and 3'-azido-2',3'-dideoxyguanosine

Article	Year
3'-Azido-2',3'-dideoxynucleoside 5'-triphosphates inhibit telomerase activity in vitro, and the corresponding nucleosides cause telomere shortening in human HL60 cells. Nucleic acids research, 2007, Volume: 35, Issue:21 Topics: Antineoplastic Agents; Cell Proliferation; Dideoxyadenosine; Dideoxynucleosides; Dideoxynucleotides; DNA; Enzyme Inhibitors; HeLa Cells; HL-60 Cells; Humans; Telomerase; Telomere; Zidovudine	2007
The base component of 3'-azido-2',3'-dideoxynucleosides influences resistance mutations selected in HIV-1 reverse transcriptase. Antimicrobial agents and chemotherapy, 2011, Volume: 55, Issue:8 Topics: Anti-HIV Agents; Azides; Base Sequence; Dideoxyadenosine; Dideoxynucleosides; Drug Resistance, Viral; HIV Reverse Transcriptase; HIV-1; Mutagenesis, Site-Directed; Reverse Transcriptase Inhibitors; Sequence Analysis, RNA; Zalcitabine; Zidovudine	2011

Article

Year

3'-Azido-2',3'-dideoxynucleoside 5'-triphosphates inhibit telomerase activity in vitro, and the corresponding nucleosides cause telomere shortening in human HL60 cells.

Nucleic acids research, 2007, Volume: 35, Issue:21

Topics: Antineoplastic Agents; Cell Proliferation; Dideoxyadenosine; Dideoxynucleosides; Dideoxynucleotides; DNA; Enzyme Inhibitors; HeLa Cells; HL-60 Cells; Humans; Telomerase; Telomere; Zidovudine

2007

The base component of 3'-azido-2',3'-dideoxynucleosides influences resistance mutations selected in HIV-1 reverse transcriptase.

Antimicrobial agents and chemotherapy, 2011, Volume: 55, Issue:8

Topics: Anti-HIV Agents; Azides; Base Sequence; Dideoxyadenosine; Dideoxynucleosides; Drug Resistance, Viral; HIV Reverse Transcriptase; HIV-1; Mutagenesis, Site-Directed; Reverse Transcriptase Inhibitors; Sequence Analysis, RNA; Zalcitabine; Zidovudine

2011